Strength
120 mg/1
Manufacturer
H2-Pharma LLCNDC
61269056590
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ORLISTATApproval Type
Authorized Generic (NDA)
FDA Application
NDA020766On Market Since
6/1/2022
Pharmacological Classes
Intestinal Lipase Inhibitor
Lipase Inhibitors
Related Drugs
Same classification
No related drugs found.